Abstract
Background
The technique of tissue tracking with balanced steady-state free precession cine sequences was introduced, and allowed myocardial strain to be derived directly, offering advantages over traditional myocardial tagging. The aim of this study was to evaluate the correlation between reverse remodeling as an outcome and left ventricular strain using cardiovascular magnetic resonance imaging (CMR) tissue tracking, and to evaluate prediction of reverse remodeling by myocardial deformation in patients with severe aortic stenosis (AS).
Methods
We enrolled 63 patients with severe AS and normal left ventricular (LV) systolic function (ejection fraction > 60%), who underwent both CMR and transthoracic echocardiography (Echo) before surgical aortic valve replacement (AVR). CMR at 1.5 T, including non and post-contrast T1 mapping for extracellular volume (ECV), was carried out to define the amount of myocardial fibrosis. Cardiac Performance Analysis software was used to derive myocardial deformation as strain parameters from three short-axis cine views (basal, mid and apical levels) and apical 2, 3, and 4 chamber views. The primary outcome was reverse remodeling, as evaluated by regression of left ventricular mass index (LVMI).
Results
Median follow-up was 28.8 months (interquartile range 11.3–38.3 months). As evaluated by LVMI between baseline and follow-up, mass regression was significantly improved after AVR (baseline 145.9 ± 37.0 [g/m2] vs. follow-up 97.7 ± 22.2[g/m2], p < 0.001). Statistically significant Pearson’s correlations with LVMI regression were observed for longitudinal global strain (r = −0.461, p < 0.001), radial strain (r = 0.391, p = 0.002), and circumferential strain (r = −0.334, p = 0.009). A simple linear regression analysis showed that all strain parameters could predict the amount of LVMI regression (P < 0.05), as well as non-contrast T1 value (beta = −0.314, p < 0.001) and ECV (beta = −2.546, p = 0.038). However, ECV had the lowest predictive power (multiple r2 = 0.071). Multiple regression analysis showed strain could independently predict the amount of LVMI regression and the longitudinal global strain (beta = −3.335, p < 0.001).
Conclusion
Longitudinal global strain measured by CMR tissue tracking as a technique was correlated with reverse remodeling as LVMI regression and was predictive of this outcome. As a simple and practical method, tissue tracking is promising to assess strain and predict reverse remodeling in severe AS, especially in patients with suboptimal Echo image quality.
Electronic supplementary material
The online version of this article (10.1186/s12968-017-0392-0) contains supplementary material, which is available to authorized users.
Keywords: Aortic stenosis, Reverse remodeling, Myocardial fibrosis, Feature tracking, Strain, Myocardial strain
Background
Patients with severe aortic stenosis (AS) are known to develop myocardial fibrosis. In AS patients, left ventricular (LV) hypertrophy and interstitial myocardial fibrosis are known sequelae of chronic pressure overload [1, 2]. Severe AS causes a pressure overloaded LV to compensate by altering its wall geometry in order to maintain wall stress [3, 4]. This hypertrophic remodeling process is pathological, with myocyte degeneration and replacement myocardial fibrosis, leading to ventricular dysfunction. Aortic valve replacement (AVR) removes aorto-valvular impedance, resulting in geometric changes (mass regression, volume reduction, and improved function) known as ‘reverse remodeling’ [5–7].
Alterations of myocardial texture resulting from AS such as myocardial fibrosis are hard to evaluate in clinical practice as there is no imaging tool to easily evaluate fibrotic changes. Non-contrast T1 values measured using cardiovascular magnetic resonance (CMR) have been correlated with diffuse myocardial fibrosis burden compared with histology in AS patients [8]. In addition, myocardial fibrosis was linked directly to AS prognosis [9], and can be measured with CMR imaging using late gadolinium enhancement (LGE) methods [10].
Myocardial strain analysis has shown to be superior to wall motion analysis to detect differences in myocardial deformation and to determine contraction timing. Myocardial deformation analysis as LV strain has been used for analysis of myocardial viability and myocardial fibrosis in various cardiac conditions [11–13]. Typically, AS causes LV pressure overload leading to LV hypertrophy, which is the basis for delayed and incomplete LV relaxation. These features of diastolic dysfunction can be quantified with CMR myocardial tagging, which has demonstrated abnormal strain and rotation values in prior studies [14–16].
CMR myocardial tissue tracking on balanced steady-state free precession (bSSFP) cine-imaging has been developed in order to satisfy the needs for fast and quantitative assessment of myocardial segmental and global strain analysis [17, 18]. CMR tissue tracking is the recently developed CMR-equivalent of speckle-tracking echocardiography [17]. CMR tissue tracking has been validated against myocardial tagging [19–21]. Importantly, CMR tissue tracking can be undertaken using bSSFP imaging, which is part of a routine CMR scan, and no additional sequences are required [22].
There are few data on the potential of CMR tissue tracking to define myocardial fibrosis and reverse remodeling in patients with severe AS. We hypothesized that the greater myocardial fibrosis is developed, the lower the degree of reverse LV remodeling. We evaluated the comparison of myocardial fibrosis using non-contrast T1 value and LV strain obtained by CMR tissue tracking. The final aims of this study were to evaluate the correlation between reverse remodeling and LV strain with a CMR tissue tracking technique and to predict reverse remodeling by myocardial deformation in patients with severe AS.
Methods
Study population and clinical outcome
The study population comprised 63 patients with severe AS and normal LV systolic function (ejection fraction > 60%) treated with surgical AVR. Patients were screened for inclusion in this study if they had been diagnosed with severe AS and were scheduled to undergo elective AVR between January 2012 and June 2015. Severe AS was defined as aortic valve area (AVA) less than 1 cm2 based on recommendations of the American Society of Echocardiography [23]. A total of 63 severe AS patients who underwent both transthoracic echocardiography (Echo) and CMR were enrolled. Patients with a glomerular filtration rate < 30 mL/min and highly impaired health status that made CMR examination impossible (severe chronic pulmonary disease, cardiac decompensation) were excluded, as were patients who met the classical contraindication for CMR (e.g., pacemaker, defibrillator, or claustrophobia).
A large number of self-reported healthy individuals undergo medical evaluation including CMR in our Health Promotion Center. From this large registry, we retrospectively selected the ten healthy individuals to serve as a control group for matching age and sex with case group. Informed consent was waived.
Echo and CMR were performed following a common standard protocol at baseline (within a week before surgery), and Echo was also performed at annual follow-up visits. Median follow-up was 28.8 months (interquartile range 11.3–38.4 months).
The end point was LV mass regression defined as the difference in LV mass index (LVMI) on preoperative Echo and the last available examination [24, 25]. The Institutional Review Board of Samsung Medical Center approved this study and all subjects gave written informed consent before the investigation.
Cardiovascular imaging – Echo and CMR
Transthoracic echocardiography (Echo)
Conventional two-dimensional Echo was performed using commercially available equipment. LV dimension and other Echo parameters were obtained according to the guidelines of the American Society of Echocardiography [26]. LV end-diastolic and end-systolic volumes were measured from apical two- and four-chamber views, and LV ejection fraction (EF) was calculated using Simpson’s rule [26]. LV mass was calculated using the formula proposed by Devereux et al. [27] and corrected by body surface area to derive LVMI. AVA was calculated by the continuity equation, and the maximum pressure gradient across the restrictive orifice was estimated by the modified Bernoulli equation. Mean pressure gradient was calculated by averaging instantaneous gradients over the ejection period on the continuous-wave Doppler recordings [23]. All study populations as well as all Echo data were re-analyzed in a blinded fashion by two experienced sonographers (RDCS), with more than 10 years’ experience or >1000 cases, and who re-evaluated LVMI by Echo in all studies.
CMR protocol – Imaging acquisition
All patients underwent CMR at 1.5-T (Magnetom Avanto, Syngo MR B17 version; Siemens Medical Solutions, Erlangen, Germany) with a 32-channel phased-array receiver coil. CMR scans consisted of localizing images (axial, coronal, and sagittal), cine scans, pre T1 mapping, perfusion scans (both stress/rest scans, with an intravenous infusion of 0.1 mmol/kg gadobutrol at an injection rate of 3 mL/s, followed by a 30 mL saline flush), LGE scans, and post-contrast T1 mapping. All examinations were carried out by experienced technicians and supervised by an experienced radiologist.
After localization, cine images of the LV were acquired using a bSSFP sequence on 4-, 3-, and 2-chamber and short axis (SA) views to obtain contiguous slices that included the entire LV with a 6-mm slice thickness and 4-mm intersection gaps. At each level, cine images were composed of 30 phases per cardiac cycle. Cine images were obtained with the generalized autocalibrating partially parallel acquisitions (GRAPPA; Siemens Medical Solutions) reconstruction algorithm during multiple breath-holds. Cine images were acquired using retrospective electrocardiogram-gating with the following parameters: repetition time/echo time, 3.31 msec/1.31 msec; flip angle, 72°; field of view, 240 × 300 mm2; matrix, 256 × 150, GRAPPA acceleration factor, 2.
T1 mapping images that were acquired in short-axis. A short-axis section at the base level was acquired using modified Look-Locker inversion-recovery (MOLLI). Pre-contrast MOLLI was composed of 5 images in the first Look-Locker segment and 3 images in the second segment (“5–3” protocol). Finally, 8 images acquired during 11 heartbeats were obtained, and in-line motion correction and map generation were performed. Post-contrast MOLLI was composed of 4 images in the first Look-Locker segment, 3 images in the second segment, and 2 images in the third segment (“4–3-2” protocol). Finally, 9 images acquired during 11 heartbeats were obtained, and in-line motion correction and map generation were performed. The following readout parameters were used: section thickness, 8 mm; flip angle, 35; field of view (FOV), 360 × 307; effective TI (TIeff), 120 msec; TIeff. Increment, 80 msec; voxel size, 1.87 × 1.88 × 8 mm; TR/TE, 2.4/1.01 ms; partial Fourier, 7/8; and parallel imaging factor, 2. Post-contrast images were produced at the same positions within 15 min after the contrast injection.
Cardiovascular magnetic resonance myocardial tissue tracking analysis
CMR tissue tracking analyses were performed using commercially available software (cvi42 version 5, Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada). Two-, three-, and four-chamber and short axis images were uploaded into the software, which reconstructs a 3D model that is used for analyses of 2D- and 3D radial, circumferential and longitudinal LV strain. The preferred images were loaded into the analysis/viewer frame of the software and analyzed in a random order by two investigators (SMK with 10 years and JWH with 3 years of CMR) who were independently blinded to the clinical findings. Tissue tracking analysis was manually performed by drawing the endo- and epicardial surface in the end-diastolic phase (reference phase) using short axis stacked slices. A short axis reference point was manually delineated at the right ventricle (RV) upper and lower septal insertion of the LV for regional and global analysis of strain and the generation of polar map views. Next the software automatically drew up the contour and traced its myocardium voxel points throughout the remainder of the cardiac cycle. The algorithm determined and depicted the left borders of the LV myocardium in the following phases during a cardiac cycle based on the endo- and epicardial contours of reference phase. Analyses of strain were performed automatically in all slices by the software in 2D as well as 3D. We used the 17-segment model for assessments of regional and global myocardial mechanics [28].
Horizontal long-axis cines were tracked to derive longitudinal global strain, while short-axis cines were used to derive radial and circumferential strain. Only one measure of strain was calculated in the radial direction, as this direction (myocardial thickening and thinning) is perpendicular to the endocardial and epicardial borders, so both contours are required to derive transmural radial strain.
Contours for tissue tracking were determined by one investigator, and tissue tracking analysis was repeated in all subjects by another independent investigator, a radiology specialist.
Statistical analyses
Continuous variables were compared using the Student’s t-test or Wilcoxon rank-sum test where applicable and are presented as mean ± standard deviations or medians with interquartile ranges (IQR). Categorical data were tested using Fisher’s exact test or the Chi-square test as appropriate. Correlations between primary outcome and strain parameters measured by CMR tissue tracking were assessed using Pearson’s method. For assessing fibrosis correlations, we also analyzed its correlation with strain parameters and non-contrast T1 value or extracellular volume (ECV).
To make a prediction on the change in LVMI regression based on any given strain value obtained with CMR tissue tracking, linear regression analysis was used. Only two cases as outliers were eliminated by Tukey’s robust outlier detection method. We also analyzed the additive value of strain parameters by CMR tissue tracking on non-contrast T1 and ECV for predicting reverse remodeling. All strain parameters (7 variables) were calculated with a stepwise multiple linear regression, and several multiple linear regression models were performed with strain parameters or baseline parameters on the following matrix of variables adjusted for age, gender, E velocity, e` velocity, max velocity of aortic valve (AV) and EF by Simpson’s method.
We calculated the inter and intra-observer interclass correlation coefficient (ICC) for LVMI by Echo. We also performed correlations between LVMI values acquired from Echo and CMR images at baseline by ICC and Bland-Altman plot.
All analyses were conducted using R software for Windows (version 3.3.2). P-values <0.05 were considered statistically significant.
Results
Baseline clinical and imaging parameters
A total of 63 patients (29 males) with severe AS who underwent surgery for AVR were included in the study. The mean age of all patients was 67.0 ± 8.5 years. The baseline characteristics of the study population are reported in Table 1. Mean LV EF of the study population was normal (60.8 ± 7.3%), and the median and interquartile range for LVMI was 137.8(117.4–166.5 [g/m2]). Additional Echo parameters and AV flow measurements are listed in Table 1.
Table 1.
Clinical characteristics and echocardiographic parameter of the study population
| Age, years | 67 (60–74) |
| Male gender | 29 (46.0%) |
| Systolic blood pressure (mmHg) | 121 (113–137) |
| Diastolic blood pressure (mmHg) | 69 (61–75) |
| Heart rate (bpm) | 69 (62–78) |
| Past medical history | |
| Atrial fibrillation | 3 (4.8%) |
| Diabetes mellitus | 13 (20.6%) |
| Hypertension | 30 (47.6%) |
| Hyperlipidemia | 17 (27.0%) |
| Ex-smoker | 6 (9.5%) |
| Current smoker | 4 (6.3%) |
| Creatinine (mg/dL) | 0.83 (0.71–1.02) |
| Diameters of aortic root and ascending aorta | |
| Diameter of aortic annulus (mm) | 21 (20–23) |
| Diameter of Sinus of Valvsalva (mm) | 33.6 (29.6–37.0) |
| Diameter of sinotubular junction (mm) | 27.8 (24.9–30.9) |
| Diameter of ascending aorta (mm) | 38.4 (34.6–42.8) |
| Baseline echocardiographic parameters | |
| LVEF (%) | 61 (56–66) |
| LVEDV(mL) | 129.1 (94–154.2) |
| LVESV (mL) | 48.9 (36–64) |
| LVEDD (mm) | 51 (48–55) |
| LVESD (mm) | 30 (27–36) |
| Interventricular septum (mm) | 12 (10–13) |
| Left ventricular posterior wall (mm) | 11 (11–12) |
| Left atrium size (mm) | 42 (39–46) |
| LAVI (mL/m2) | 43.6 (37.3–54.9) |
| LVMI (g/m2) | 137.8 (117.4–166.5) |
| E velocity (m/s) | 0.69 (0.53–1.04) |
| Deceleration time (msec) | 264 (209–322) |
| e’ velocity (m/s) | 0.05 (0.04–0.06) |
| E/e’ ratio | 15.06 (10.63–20.51) |
| Parameters of grade of aortic stenosis | |
| Max velocity of AV(m/s) | 5.26 (4.56–5.62) |
| AV velocity time integral (cm) | 123.7 (106.6–146.7) |
| Mean pressure gradient of AV (mmHg) | 61.7 (50.1–78.9) |
| LVOT velocity time integral (cm) | 24.8 (21.6–29.7) |
| AVA (cm2) | 0.72 (0.57–0.83) |
| AVAI (cm2/m2) | 0.44 (0.38–0.51) |
Data are presented are number of patients (percent) or median (interquartile range)
LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVEDD left ventricular end-diastolic dimension, LVESV left ventricular end-systolic dimension, LAVI left atrium volume index, LVMI left ventricular mass index, AV aortic valve, LVOT left ventricular outflow tract, AVA aortic valve area, AVAI aortic valve area (indexed)
The LVMI measured by Echo inter-observer ICC was 0.85 (95% confidence interval: 0.79–0.89, p < 0.001) and the intra-observer ICC was 0.86 (95% confidence interval: 0.81–0.90, p < 0.001). In addition, there was a positive correlation between LVMI values of the baseline Echo and CMR images (r = 0.73, p < 0.001), and ICC was 0.723 (95% confidence interval: 0.580–0.823, p < 0.001). We also presented the Bland-Altman plot with LVMI values of the baseline Echo and CMR (Additional file 1: Figure S1). The median time duration from AVR to follow-up Echo was 833 days (interquartile range 372–1183 days) (Additional file 1: Figure S2).
Correlation of non-contrast T1 value, extracellular volume, and strain parameters by CMR tissue tracking
We selected 10 healthy individuals of similar age and gender to compare with the 10 patients (the study population with severe AS) on non-contrast T1 value and ECV. The fibrosis quantification as measured by CMR was significantly different between patients with severe AS and healthy controls in terms of non-contrast T1 value and ECV (non-contrast T1 value [1024.4 ± 36.7 vs. 968.3 ± 52.0, p = 0.013] and ECV [28.0± 2.6 vs. 23.5 ± 1.3, p < 0.001]). The T1 value of healthy individuals was consistent with previous studies, as 1029.4 ± 56.8 by Nacif et al. [29], and 1025 ± 41 by Roujol et al. [30].
There was a negative correlation between the amount of myocardial fibrosis determined by non-contrast T1 value and longitudinal global strain (r = 0.445, p < 0.001) and 3D longitudinal global strain (r = 0.389, p = 0.002) by CMR tissue tracking (Fig. 1a). There was a significant negative correlation between non-contrast T1 value and radial strain (r = −0.384, p = 0.002) and 3D radial strain (r = −0.368, p = 0.004) (Fig. 1b). Additionally, there was also a negative correlation between non-contrast T1 value and circumferential strain (r = 0.364, p = 0.004) and 3D circumferential strain (r = 0.455, p < 0.001) (Fig. 1c).
Fig. 1.
Correlation between non-contrast T1 value and strain measure by cardiovascular magnetic resonance (CMR) tissue tracking. Various kinds of strain including longitudinal strain, 3D longitudinal strain, radial strain, 3D radial strain, circumferential strain, and 3D circumferential strain by CMR were compared with non-contrast T1 values
ECV showed a similar correlation pattern with strain by tissue tracking as a non-contrast T1 value. There was a negative correlation between ECV and longitudinal global strain (r = 0.354, p = 0.005) and 3D longitudinal global strain (r = 0.429, p < 0.001) by CMR-tissue tracking. There was a significant negative correlation between ECV and radial strain (r = −0.322, p = 0.012) and 3D radial strain (r = −0.287, p = 0.025). Additionally, there was also a negative correlation between ECV and circumferential strain (r = 0.344, p = 0.007) and 3D circumferential strain (r = 0.408, p = 0.001) (Fig. 2c).
Fig. 2.
Correlation between the value of extracellular volume (ECV) and strain measure by CMR tissue tracking. Various kinds of strain including longitudinal strain, 3D longitudinal strain, radial strain, 3D radial strain, circumferential strain, and 3D circumferential strain by cardiac magnetic resonance were compared with ECV
Left ventricle reverse remodeling and strain by CMR tissue tracking
The result of baseline and follow-up Echo are shown in Fig. 3a. LVMI was 145.9 ± 37.0 (g/m2) on baseline study of Echo and 97.7 ± 22.2 (g/m2) on follow-up study. Additionally, as follow-up there was a significant LVMI reduction (the difference of LVMI: −48.2 ± 30.0 [g/m2], p < 0.001).
Fig. 3.
Correlation between left ventricle (LV) reverse remodeling by transthoracic echocardiography (Echo) and strain by CMR tissue tracking. This was compared using left ventricular mass index (LVMI) between baseline and follow-up by Echo. Correlation between reverse remodeling as LVMI difference between baseline and follow-up Echo and respective strain measured by CMR tissue tracking. (SD; standard deviation, LVMI; left ventricular mass index)
Significant Pearson’s correlations were seen between reverse remodeling defined as LVMI difference between baseline and follow-up Echo, and longitudinal global strain (r = −0.461, p < 0.001), radial strain (r = 0.391, p = 0.002) and circumferential strain (r = −0.334, p = 0.009). All types of 3D strain were also correlated with reverse remodeling, including 3D longitudinal global strain (r = −0.405, p = 0.001), 3D radial strain (r = 0.405, p = 0.001) and 3D circumferential strain (r = −0.420, p < 0.001) (Fig. 3).
To perform linear regression analysis, outliers were eliminated, and finally 61 cases were analyzed. Simple linear regression showed strain parameters measured by CMR tissue tracking could predict LVMI regression, in terms of longitudinal global strain (beta = −3.533, p < 0.001), radial strain (beta = 0.860, p = 0.002), and circumferential strain (beta = −3.360, p < 0.001). The all types category for other types of 3D strain also predicted the outcome, as well as 3D longitudinal global strain (beta = −4.107, p = 0.001), 3D radial strain (beta = 0.914, p = 0.001), and 3D circumferential strain (beta = −3.360, p < 0.001). In terms of results, the degree of reverse remodeling prediction was similar between 2D and 3D deformation parameters.
The non-contrast T1 value (beta = −0.314, p < 0.001) and ECV (beta = −2.55, p = 0.038) predicted outcomes. However, ECV had the lowest predictive power (multiple r2 = 0.071). We also analyzed the additive value of all strain parameters based on non-contrast T1 and ECV. After adding the strain parameters measure by CMR tissue tracking respectively, its predictive powers were significantly increased (Table 2). Additionally, we also performed an analysis on the presence of late gadolinium enhancement and reverse remodeling, but it was not significant in a linear regression (beta = 8.327, p = 0.17).
Table 2.
Simple linear regression analysis of variables for the prediction of left ventricular reverse remodeling
| Multiple r2 | Adjusted r2 | Estimated beta | Standard error | p-value | |
|---|---|---|---|---|---|
| longitudinal global strain | 0.213 | 0.199 | −3.533 | 0.885 | <0.001 |
| 3D longitudinal global strain | 0.164 | 0.15 | −4.107 | 1.206 | 0.001 |
| radial strain | 0.153 | 0.138 | 0.86 | 0.264 | 0.002 |
| 3D radial strain | 0.164 | 0.15 | 0.914 | 0.268 | 0.001 |
| circumferential strain | 0.112 | 0.097 | −2.532 | 0.93 | 0.009 |
| 3D circumferential strain | 0.177 | 0.163 | −3.36 | 0.945 | <0.001 |
| non-contrast T1 value | 0.191 | 0.177 | −0.314 | 0.084 | <0.001 |
| extracellular volume after 15 min | 0.071 | 0.055 | −2.546 | 1.201 | 0.038 |
| Additive value of strain parameters | |||||
| non-contrast T1 value | |||||
| longitudinal global strain | 0.280 | 0.255 | −2.549 | 0.954 | 0.01 |
| 3D longitudinal global strain | 0.256 | 0.23 | −2.81 | 1.245 | 0.028 |
| radial strain | 0.249 | 0.223 | 0.575 | 0.271 | 0.038 |
| 3D radial strain | 0.260 | 0.234 | 0.638 | 0.274 | 0.023 |
| circumferential strain | 0.226 | 0.199 | −1.529 | 0.94 | 0.11 |
| 3D circumferential strain | 0.253 | 0.227 | −2.234 | 1.019 | 0.032 |
| extracellular volume after 15 min | |||||
| longitudinal global strain | 0.225 | 0.198 | −3.214 | 0.947 | 0.001 |
| 3D longitudinal global strain | 0.175 | 0.146 | −3.616 | 1.338 | 0.009 |
| radial strain | 0.175 | 0.146 | 0.749 | 0.277 | 0.009 |
| 3D radial strain | 0.189 | 0.161 | 0.808 | 0.278 | 0.005 |
| circumferential strain | 0.138 | 0.108 | −2.085 | 0.984 | 0.038 |
| 3D circumferential strain | 0.187 | 0.159 | −2.99 | 1.037 | 0.006 |
All strain parameters were measured by cardiovascular magnetic resonance myocardial tissue tracking
Initially, 3D circumferential strain was only selected in an adjusted stepwise multiple regression analysis of 6 strain parameters, for analysis of main effects. Then, we created two models: Model 1, the stepwise selection was adjusted with interaction effects in mind; Model 2, included the main effect term with adjustments for baseline parameters including age, gender, E velocity, e` velocity, max velocity of AV, and EF by Simpson’s method. Multiple regression analysis also showed that longitudinal global strain (beta = −3.335, p < 0.001) independently predicted the amount of LVMI regression (Table 3).
Table 3.
Multiple linear regression analysis of variables for the prediction of left ventricular reverse remodeling
| Estimated beta | standard error | p-value | ||
|---|---|---|---|---|
| Model 1 | radial strain | 1.834 | 0.839 | 0.033 |
| circumferential strain | 7.527 | 3.275 | 0.026 | |
| longitudinal global strain | −38.444 | 11.797 | 0.002 | |
| 3D circumferential strain | 30.932 | 12.572 | 0.017 | |
| 3D longitudinal global strain | −4.123 | 6.884 | 0.55 | |
| longitudinal global strain: 3D longitudinal global strain | −2.390 | 0.796 | 0.004 | |
| 3D circumferential strain: 3D longitudinal global strain | 2.179 | 0.840 | 0.012 | |
| Model 2 | max velocity of aortic valve | −12.566 | 4.845 | 0.012 |
| longitudinal global strain | −3.335 | 0.849 | <0.001 |
All strain parameters (6 variables) were calculated by a stepwise multiple linear regression analysis, and several multiple linear regression models were performed with strain parameters or baseline parameters; Model 1, adjusting the stepwise selection as considered with interaction; Model 2, including the main effect term adjusting with baseline parameters such as the age, gender, E velocity, e` velocity, max velocity of aortic valve, ejection fraction by Simpson’s method
All strain parameters were measured by cardiovascular magnetic resonance myocardial tissue tracking
Discussion
The main findings of the study are that 1) CMR tissue tracking and amount of myocardial fibrosis determined by non-contrast T1 value were significantly correlated; 2) ECV showed a similar correlation pattern with strain by tissue tracking as a non-contrast T1 value; and 3) reverse remodeling as the difference in LVMI between baseline and follow-up Echo was also significantly correlated with myocardial strain by CMR tissue tracking. Global longitudinal strain measured by CMR tissue tracking independently predicted the amount of LVMI regression. In addition, there was some information about the relation between strain and LVMI after AVR in patients with severe AS.
The ability to quantify diffuse myocardial fibrosis in patients noninvasively is of considerable clinical interest, as the pathology of diffuse myocardial fibrosis is reversible with treatment and therefore a potential treatment target [9, 31, 32]. Although widespread and diffuse, the distribution of interstitial myocardial fibrosis in chronic AV disease can be regionally accentuated [33]. CMR can determine the presence, distribution, and quantity of myocardial fibrosis [34]. This study provided further support for the role of CMR tissue tracking as a technique, which demonstrated significant correlation with non-contrast T1 values for assessing myocardial fibrosis.
LV hypertrophy produced by pressure overload in AS is an adaptation that compensates for high intracavitary pressures with the goal of normalizing wall stress and maintaining adequate cardiac output [35, 36]. Persistently elevated systolic wall stress and compromised myocardial perfusion lead to myocyte degeneration and myocardial fibrosis, with a significant relationship between the degree of such morphological alterations and LV function [1, 37, 38]. Azevedo and colleagues also observed that greater degrees of myocardial fibrosis were associated with worse long-term survival after AVR [10]. Removing valvular impedance and wall stress allows ‘reverse remodeling’ of the ventricle and thus improves patient symptoms and prognosis. The beneficial effects of AVR are mainly attributable to a decrease in LV pressure overload, allowing LV mass decrease and regression of hypertrophy [5, 14, 39].
The non-contrast T1 value or ECV could estimate the degree of myocardial fibrosis as anatomical change. On the other hand, the CMR strain parameters by tissue tracking could reflect functional change as deformation parameters. In spite of the low correlation between these parameters, the deformation parameters of CMR strain may be useful outcome parameters without additional T1 mapping sequences. We confirmed that myocardial strain by CMR tissue tracking can independently predict reverse remodeling as LVMI difference, however, the max velocity of AV, mean pressure gradient of AV, and EF as Echo parameters were not significant predictors.
The LV wall is not homogenous and is composed of endocardial, mid-myocardial, and epicardial layers [40]. LV function is determined by the sum of contraction and relaxation in these three layers [41, 42]. As with the progression of AS, the early stage of myocardial fibrosis can develop into subendocardial layers. The results of our study showed that longitudinal global strain as longitudinal function could significantly predict LVMI regression. Only longitudinal function could detect the early progression of myocardial fibrosis. Circumferential strain and radial strain could not detect the early stage of fibrosis progression, because they are related to midwall function. Strain imaging has been demonstrated to be the most appropriate method to evaluate LV myocardial contractility properties and myocardial deformation, as strain may enable a better characterization of subtle changes in LV performance in severe AS patients [43, 44].
CMR tissue tracking is most effective around endocardial borders, most of which are trabeculated [45]. A limitation is the temporal resolution, which may not be able to resolve short-lived phases of cardiac motion in CMR. The frame rate depends on heart rate and various acquisition parameters. Since CMR acquisitions obtain data over several heart beats minor beat-to-beat differences are smoothed out which, in combination with suboptimal temporal resolution, will obscure rapid isovolumic phases and might lead to underestimation of displacement and strain values [46–48].
Tissue tracking was initially developed for 2D images, but the technology can, in principle, be extended to track 3D volumetric regions As a result, some 3D tissue tracking solutions are currently available, although experience with them is still limited [49, 50]. When this extension is feasible, local 3D tissue features may be tracked simultaneously in all directions to derive all deformation parameters. This could theoretically reduce artifacts in deformation such as those that may result from through-plane displacements of 3D structures [51]. 3D acquisitions with comparable resolution in all three orthogonal directions are technically feasible. Although these have yet to be widely implemented, they can be achieved by using relatively long, navigated acquisitions and fast compressed sensing techniques [51].
Analysis of myocardial motion with CMR-tagging is an important tool for the assessment of LV function in several conditions [48], and may help to identify patients before the onset of overt myocardial dysfunction. CMR-tagging has become the reference standard for the evaluation of regional myocardial function [46, 52]. However, CMR-tagging requires specialized tagging sequences and lengthy breath-holds, and the post-processing procedure is laborious and time-consuming [20]. Myocardial tagging may suffer from progressive attenuation of the tag signal during the cardiac cycle [53].
In contrast, CMR tissue tracking requires no acquisitions other than a SSFP sequence, the ‘workhorse’ sequence in CMR. As a further advantage over SPAtial Modulation of Magnetization (SPAMM), in which myocardial tags fade toward the end of diastole, CMR tissue tracking permits measurement of motion and strain throughout the whole cardiac cycle. CMR more consistently provides high-quality imaging with complete LV anatomical regional coverage. CMR tissue tracking does not require additional imaging. Using software, CMR tissue tracking analysis can be performed using routine CMR cine images in less than 10 min [51, 54].
Limitations
The main limitation of this study is that it is a single center study that included only a small number of patients.
Tissue tagging is still considered the gold standard for strain analysis for research purposes. We could not compare CMR tissue tracking and tissue tagging/SPAMM. In two previous studies, the comparison of CMR tissue tracking and tissue tagging was reported in patients with AS [20, 47]. Until now, there has been no tissue tracking standard reference. Further investigations in different diseases and healthy patients should determine if tissue tracking can serve as a reliable alternative to tagging.
We analyzed the quantification of fibrosis on T1 mapping technique rather than late gadolinium enhancement. T1 mapping is superior at detecting the diffuse fibrosis seen in the pressure overloaded ventricle [8]. Nevertheless, we need to further validate the quantification of fibrosis as tissue tracking in large-scaled population.
Differences in LVMI were measured with the use of 2D Echo. For accurate LVMI measurement, the gold standard is CMR. In this study, baseline LVMI was measured with Echo and CMR. However, only Echo was performed in annual follow-ups. Furthermore, in evaluating LV mass regression in patients with severe AS, we need to assess follow-up CMR after AVR.
Conclusion
We have shown that longitudinal global strain measured by CMR tissue tracking correlated with the amount of myocardial fibrosis determined by non-contrast T1 values in patients with severe AS. The application of this technique as CMR tissue tracking is feasible in a clinical setting and it has the potential to be used as a simple, non-invasive, non-contrast assessment of myocardial fibrosis using cine sequences. In addition, reverse remodeling as LVMI difference was significantly correlated with myocardial strain by CMR tissue tracking, and longitudinal global strain independently predicted LVMI regression. Further work is needed to determine the role of tissue tracking for monitoring reverse remodeling and to aid risk stratification of AS patients.
Acknowledgements
Not applicable.
Availability of data and materials
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.
Abbreviations
- AS
Aortic stenosis
- AV
Aortic valve
- AVA
Aortic valve area
- AVR
Aortic valve replacement
- CMR
Cardiovascular magnetic resonance
- Echo
Transthoracic echocardiography
- EF
Ejection fraction
- LV
Left ventricle/left ventricular
- LVMI
Left ventricular mass index
Additional file
Figure S1. Bland-Altman plot with LVMI values of the baseline Echo and CMR. There was a positive correlation between LVMI values of the baseline Echo and CMR images (r = 0.73, p < 0.001), and ICC was 0.723 (95% confidence interval: 0.580–0.823, p < 0.001). Figure S2. The median time duration from AVR to follow-up Echo (median days [interquartile range]: 833[372–1183] days) (PPTX 82 kb)
Authors’ contributions
SJP and SMK designed the study. JWH and SMK analyzed statistics and interpreted the patient data. EKK and EJC collected data. JWH and SMK wrote the manuscript. SAC, SCL, YHC, SWP and SJP revised the manuscript. All authors read and approved the final manuscript.
Funding
Not applicable.
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of Samsung Medical Center, and the requirement for informed consent was waived because of using the medical records retrospectively.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Footnotes
Electronic supplementary material
The online version of this article (10.1186/s12968-017-0392-0) contains supplementary material, which is available to authorized users.
Contributor Information
Ji-won Hwang, Email: enigma1012@hanmail.net.
Sung Mok Kim, Email: sm5040.kim@samsung.com.
Sung-Ji Park, Phone: 82-2-3410-3419, Email: tyche.park@gmail.com.
Eun Jeong Cho, Email: ounjungcho@daum.net.
Eun Kyoung Kim, Email: ekbobi.kim@samsung.com.
Sung-A Chang, Email: sunga.chang@samsung.com.
Sang-Chol Lee, Email: sc.lea@samsunug.com.
Yeon Hyeon Choe, Email: yh.choe@samsung.com.
Seung Woo Park, Email: parksmc@gmail.com.
References
- 1.Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–991. doi: 10.1161/01.CIR.0000051865.66123.B7. [DOI] [PubMed] [Google Scholar]
- 2.Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation. 2005;112:1136–1144. doi: 10.1161/CIRCULATIONAHA.104.516963. [DOI] [PubMed] [Google Scholar]
- 3.Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med. 1980;69:576–584. doi: 10.1016/0002-9343(80)90471-4. [DOI] [PubMed] [Google Scholar]
- 4.Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med. 1992;327:998–1008. doi: 10.1056/NEJM199210013271406. [DOI] [PubMed] [Google Scholar]
- 5.Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99:1185–1191. doi: 10.1136/heartjnl-2013-303927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195–202. doi: 10.1016/0735-1097(95)00153-Q. [DOI] [PubMed] [Google Scholar]
- 7.Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS substudy. JACC Cardiovasc Imaging. 2009;2:390–399. doi: 10.1016/j.jcmg.2008.12.021. [DOI] [PubMed] [Google Scholar]
- 8.Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99:932–937. doi: 10.1136/heartjnl-2012-303052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58:1271–1279. doi: 10.1016/j.jacc.2011.03.064. [DOI] [PubMed] [Google Scholar]
- 10.Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56:278–287. doi: 10.1016/j.jacc.2009.12.074. [DOI] [PubMed] [Google Scholar]
- 11.Cameli M, Mondillo S, Righini FM, Lisi M, Dokollari A, Lindqvist P, et al. Left ventricular deformation and myocardial fibrosis in patients with advanced heart failure requiring transplantation. J Card Fail. 2016; [DOI] [PubMed]
- 12.Almaas VM, Haugaa KH, Strom EH, Scott H, Smith HJ, Dahl CP, et al. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart. 2014;100:631–638. doi: 10.1136/heartjnl-2013-304923. [DOI] [PubMed] [Google Scholar]
- 13.Hoffmann R, Altiok E, Friedman Z, Becker M, Frick M. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis. Am J Cardiol. 2014;114:1083–1088. doi: 10.1016/j.amjcard.2014.07.018. [DOI] [PubMed] [Google Scholar]
- 14.Biederman RW, Doyle M, Yamrozik J, Williams RB, Rathi VK, Vido D, et al. Physiologic compensation is supranormal in compensated aortic stenosis: does it return to normal after aortic valve replacement or is it blunted by coexistent coronary artery disease? An intramyocardial magnetic resonance imaging study. Circulation. 2005;112:I429–I436. doi: 10.1161/CIRCULATIONAHA.104.525501. [DOI] [PubMed] [Google Scholar]
- 15.Nagel E, Stuber M, Burkhard B, Fischer SE, Scheidegger MB, Boesiger P, et al. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur Heart J. 2000;21:582–589. doi: 10.1053/euhj.1999.1736. [DOI] [PubMed] [Google Scholar]
- 16.Stuber M, Scheidegger MB, Fischer SE, Nagel E, Steinemann F, Hess OM, et al. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation. 1999;100:361–368. doi: 10.1161/01.CIR.100.4.361. [DOI] [PubMed] [Google Scholar]
- 17.Hor KN, Baumann R, Pedrizzetti G, Tonti G, Gottliebson WM, Taylor M, et al. Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp. 2011; [DOI] [PMC free article] [PubMed]
- 18.Maret E, Todt T, Brudin L, Nylander E, Swahn E, Ohlsson JL, et al. Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovasc Ultrasound. 2009;7:53. doi: 10.1186/1476-7120-7-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harrild DM, Han Y, Geva T, Zhou J, Marcus E, Powell AJ. Comparison of cardiac MRI tissue tracking and myocardial tagging for assessment of regional ventricular strain. Int J Cardiovasc Imaging. 2012;28:2009–2018. doi: 10.1007/s10554-012-0035-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Schneeweis C, Lapinskas T, Schnackenburg B, Berger A, Hucko T, Kelle S, et al. Comparison of myocardial tagging and feature tracking in patients with severe aortic stenosis. J Heart Valve Dis. 2014;23:432–440. [PubMed] [Google Scholar]
- 21.Hor KN, Gottliebson WM, Carson C, Wash E, Cnota J, Fleck R, et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging. 2010;3:144–151. doi: 10.1016/j.jcmg.2009.11.006. [DOI] [PubMed] [Google Scholar]
- 22.Wu L, Germans T, Guclu A, Heymans MW, Allaart CP, van Rossum AC. Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:10. doi: 10.1186/1532-429X-16-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1–23. doi: 10.1016/j.echo.2008.11.029. [DOI] [PubMed] [Google Scholar]
- 24.Gelsomino S, Luca F, Parise O, Lorusso R, Rao CM, Vizzardi E, et al. Longitudinal strain predicts left ventricular mass regression after aortic valve replacement for severe aortic stenosis and preserved left ventricular function. Heart Vessel. 2013;28:775–784. doi: 10.1007/s00380-012-0308-8. [DOI] [PubMed] [Google Scholar]
- 25.Dobson LE, Fairbairn TA, Musa TA, Uddin A, Mundie CA, Swoboda PP, et al. Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: a cardiovascular magnetic resonance study. Am Heart J. 2016;175:101–111. doi: 10.1016/j.ahj.2016.02.010. [DOI] [PubMed] [Google Scholar]
- 26.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14. [DOI] [PubMed]
- 27.Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458. doi: 10.1016/0002-9149(86)90771-X. [DOI] [PubMed] [Google Scholar]
- 28.Schuster A, Stahnke VC, Unterberg-Buchwald C, Kowallick JT, Lamata P, Steinmetz M, et al. Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility. Clin Radiol. 2015;70:989–998. doi: 10.1016/j.crad.2015.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nacif MS, Turkbey EB, Gai N, Nazarian S, van der Geest RJ, Noureldin RA, et al. Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging. 2011;34:1367–1373. doi: 10.1002/jmri.22753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Roujol S, Weingartner S, Foppa M, Chow K, Kawaji K, Ngo LH, et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology. 2014;272:683–689. doi: 10.1148/radiol.14140296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105:2512–2517. doi: 10.1161/01.CIR.0000017264.66561.3D. [DOI] [PubMed] [Google Scholar]
- 32.Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. 1989;79:744–755. doi: 10.1161/01.CIR.79.4.744. [DOI] [PubMed] [Google Scholar]
- 33.Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. AJR Am J Roentgenol. 2006;187:W630–W635. doi: 10.2214/AJR.05.1264. [DOI] [PubMed] [Google Scholar]
- 34.Kwong RY, Farzaneh-Far A. Measuring myocardial scar by CMR. JACC Cardiovasc Imaging. 2011;4:157–160. doi: 10.1016/j.jcmg.2010.12.004. [DOI] [PubMed] [Google Scholar]
- 35.Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956–966. doi: 10.1016/S0140-6736(09)60211-7. [DOI] [PubMed] [Google Scholar]
- 36.Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322:1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
- 37.Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension. 2004;43:716–719. doi: 10.1161/01.HYP.0000118586.38323.5b. [DOI] [PubMed] [Google Scholar]
- 38.Ahn JH, Kim SM, Park SJ, Jeong DS, Woo MA, Jung SH, et al. Coronary microvascular dysfunction as a mechanism of angina in severe AS: prospective adenosine-stress CMR study. J Am Coll Cardiol. 2016;67:1412–1422. doi: 10.1016/j.jacc.2016.01.013. [DOI] [PubMed] [Google Scholar]
- 39.Breitenbach I, Harringer W, Tsui S, Amorim MJ, Herregods MC, Bogaert J, et al. Magnetic resonance imaging versus echocardiography to ascertain the regression of left ventricular hypertrophy after bioprosthetic aortic valve replacement: results of the REST study. J Thorac Cardiovasc Surg. 2012;144(640-5):e1. doi: 10.1016/j.jtcvs.2011.11.017. [DOI] [PubMed] [Google Scholar]
- 40.Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120:577–584. doi: 10.1161/CIRCULATIONAHA.108.847772. [DOI] [PubMed] [Google Scholar]
- 41.Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J. 1981;45:248–263. doi: 10.1136/hrt.45.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Leitman M, Lysiansky M, Lysyansky P, Friedman Z, Tyomkin V, Fuchs T, et al. Circumferential and longitudinal strain in 3 myocardial layers in normal subjects and in patients with regional left ventricular dysfunction. J Am Soc Echocardiogr. 2010;23:64–70. doi: 10.1016/j.echo.2009.10.004. [DOI] [PubMed] [Google Scholar]
- 43.Korinek J, Wang J, Sengupta PP, Miyazaki C, Kjaergaard J, McMahon E, et al. Two-dimensional strain--a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. J Am Soc Echocardiogr. 2005;18:1247–1253. doi: 10.1016/j.echo.2005.03.024. [DOI] [PubMed] [Google Scholar]
- 44.Weidemann F, Jamal F, Kowalski M, Kukulski T, D'Hooge J, Bijnens B, et al. Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing--implications for quantitative stress echocardiography. J Am Soc Echocardiogr. 2002;15:416–424. doi: 10.1067/mje.2002.116535. [DOI] [PubMed] [Google Scholar]
- 45.Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S. Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging. 2016;9:e004077. doi: 10.1161/CIRCIMAGING.115.004077. [DOI] [PubMed] [Google Scholar]
- 46.Shehata ML, Cheng S, Osman NF, Bluemke DA, Lima JA. Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2009;11:55. doi: 10.1186/1532-429X-11-55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Singh A, Steadman CD, Khan JN, Horsfield MA, Bekele S, Nazir SA, et al. Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 tesla: a comparison of feature-tracking and tagging in patients with aortic stenosis. J Magn Reson Imaging. 2015;41:1129–1137. doi: 10.1002/jmri.24625. [DOI] [PubMed] [Google Scholar]
- 48.Gotte MJ, Germans T, Russel IK, Zwanenburg JJ, Marcus JT, van Rossum AC, et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J Am Coll Cardiol. 2006;48:2002–2011. doi: 10.1016/j.jacc.2006.07.048. [DOI] [PubMed] [Google Scholar]
- 49.Spottiswoode BS, Zhong X, Lorenz CH, Mayosi BM, Meintjes EM, Epstein FH. 3D myocardial tissue tracking with slice followed cine DENSE MRI. J Magn Reson Imaging. 2008;27:1019–1027. doi: 10.1002/jmri.21317. [DOI] [PubMed] [Google Scholar]
- 50.Claus P, Omar AM, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking Technology for Assessing Cardiac Mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging. 2015;8:1444–1460. doi: 10.1016/j.jcmg.2015.11.001. [DOI] [PubMed] [Google Scholar]
- 51.Pedrizzetti G, Claus P, Kilner PJ, Nagel E. Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson. 2016;18:51. doi: 10.1186/s12968-016-0269-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JA, Smiseth OA. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation. 2002;106:50–56. doi: 10.1161/01.CIR.0000019907.77526.75. [DOI] [PubMed] [Google Scholar]
- 53.Markl M, Reeder SB, Chan FP, Alley MT, Herfkens RJ, Pelc NJ. Steady-state free precession MR imaging: improved myocardial tag persistence and signal-to-noise ratio for analysis of myocardial motion. Radiology. 2004;230:852–861. doi: 10.1148/radiol.2303030181. [DOI] [PubMed] [Google Scholar]
- 54.Taylor RJ, Moody WE, Umar F, Edwards NC, Taylor TJ, Stegemann B, et al. Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values. Eur Heart J Cardiovasc Imaging. 2015;16:871–881. doi: 10.1093/ehjci/jev006. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.